Pfizer Inc. plans to resume its practice of raising drug prices early next year after bowing to pressure from President Trump over the summer when the company rolled back some increases.
Pfizer, among the world’s biggest drugmakers by sales, won’t be raising prices as much as it has in past years.
the 49-year-old former CVSHealth and Pfizer Pharmaceuticals executive agreed to work at HHS “out of a desire to serve the American people by making health care more affordable.”
Daniel Best, a pharmaceutical executive from Bay Village who was tapped to oversee government efforts to reduce prescription drug costs, died on Nov. 1. (Photo courtesy of the U.S. Department of Health and Human Services)